With the introduction of Dihydroartemisinin-piperaquine (DHAP) and artesunate-pyronaridine (ASPY) on the list of anti-malarial drugs available in Rwanda, the number of treatments that can be ...

An anti-malaria drug that has saved millions of lives may be losing its effectiveness. In Africa, where many children are at risk, medical professionals are worried. NPR's Gabrielle Emanuel ...

Veterans and military personnel who suffered debilitating side-effects from the controversial anti-malarial drug Lariam have launched a groundbreaking legal battle against the Ministry of Defence.

As billions of dollars are committed to tackling malaria and HIV in Africa yearly, one disease is killing more people than ...

Some Ugandan children with complicated malaria have shown partial resistance to leading anti-malarial drug artemisinin. What challenge does this pose to treatment efficacy and raising concerns ...

In contrast, sales revenues from Anti-malarial drugs are forecast to decline from Ush100.9 billion ($27 million) in 2024 to ...

Novel anti-malaria antibodies have been identified, potentially contributing to the next generation of malaria prevention. Researchers at the National Institutes of Health (MD, USA) have identified a ...

Augusta Cueva-Agila explains how the Cinchona officinalis, native to the Andean foothills, produced the world’s first anti-malarial drug ...